Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Insulin Like Growth Factor I Pipeline Drugs Market Overview
Insulin-like growth factor 1 (IGF-1) also called somatomedin C is a protein encoded by the IGF1 gene. It stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin. It plays a role in synapse maturation. It acts as a ligand for IGF1R. The Insulin Like Growth Factor I pipeline drugs market research report provides comprehensive information on the therapeutics under development for Fibroblast Growth Factor 2, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases.
Insulin Like Growth Factor I Pipeline Drugs Market Segmentation by Therapy Areas
The key therapy areas of the Insulin Like Growth Factor I pipeline drugs market are oncology, central nervous system, cardiovascular, metabolic disorders, musculoskeletal disorders, and ophthalmology.
Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Therapy Areas, 2022 (%)
For more therapy area insights into the Insulin Like Growth Factor I pipeline drugs market, download a free report sample
Insulin Like Growth Factor I Pipeline Drugs Market Segmentation by Mechanisms of Action
The key mechanisms of action of the Insulin Like Growth Factor I pipeline drugs market are Insulin Like Growth Factor I Inhibitor, and Insulin Like Growth Factor I Activator.
Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Mechanisms of Action, 2022 (%)
For more mechanisms of action insights into the Insulin Like Growth Factor I pipeline drugs market, download a free report sample
Insulin Like Growth Factor I Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the Insulin Like Growth Factor I pipeline drugs market are intravenous, intramuscular, intravenous bolus, and ophthalmic.
Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Routes of Administration, 2022 (%)
For more routes of administration insights into the Insulin Like Growth Factor I pipeline drugs market, download a free report sample
Insulin Like Growth Factor I Pipeline Drugs Market Segmentation by Molecule Types
The key molecule types in the Insulin Like Growth Factor I pipeline drugs market are monoclonal antibody, synthetic peptide, cell therapy, gene therapy, peptide, and recombinant protein.
Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Molecule Types, 2022 (%)
For more molecule type insights into the Insulin Like Growth Factor I pipeline drugs market, download a free report sample
Insulin Like Growth Factor I Pipeline Drugs Market - Competitive Landscape
Some of the leading companies in the Insulin Like Growth Factor I pipeline drugs market are Boehringer Ingelheim International GmbH, Genervon Biopharmaceuticals LLC, Helixmith Co Ltd, Regulaxis SAS, SIFI SpA, and Stem Cell Medicine Ltd.
Insulin Like Growth Factor I Pipeline Drugs Market Analysis, by Companies, 2022 (%)
To know more about the companies in the Insulin Like Growth Factor I pipeline drugs market, download a free report sample
Insulin Like Growth Factor I Pipeline Drugs Market Report Overview
Key Therapy Areas | Oncology, Central Nervous System, Cardiovascular, Metabolic Disorders, Musculoskeletal Disorders, and Ophthalmology |
Key Mechanisms of Action | Insulin Like Growth Factor I Inhibitor, and Insulin Like Growth Factor I Activator |
Key Routes of Administration | Intravenous, Intramuscular, Intravenous Bolus, and Ophthalmic |
Key Molecule Types | Monoclonal Antibody, Synthetic Peptide, Cell Therapy, Gene Therapy, Peptide, and Recombinant Protein |
Leading Companies | Boehringer Ingelheim International GmbH, Genervon Biopharmaceuticals LLC, Helixmith Co Ltd, Regulaxis SAS, SIFI SpA, and Stem Cell Medicine Ltd |
Segments Covered in the Report
Insulin Like Growth Factor I Pipeline Drugs Market Therapy Areas Outlook
- Oncology
- Central Nervous System
- Cardiovascular
- Metabolic Disorders
- Musculoskeletal Disorders
- Ophthalmology
Insulin Like Growth Factor I Pipeline Drugs Market Mechanisms of Action Outlook
- Insulin Like Growth Factor I Inhibitor
- Insulin Like Growth Factor I Activator
Insulin Like Growth Factor I Pipeline Drugs Market Routes of Administration Outlook
- Intravenous
- Intramuscular
- Intravenous Bolus
- Ophthalmic
Insulin Like Growth Factor I Pipeline Drugs Market Molecule Types Outlook
- Monoclonal Antibody
- Synthetic Peptide
- Cell Therapy
- Gene Therapy
- Peptide
- Recombinant Protein
Scope
- The report provides a snapshot of the global therapeutic landscape for Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1)
- The report reviews Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) targeted therapeutics and enlists all their major and minor projects
- The report assesses Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) targeted therapeutics
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1)Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Genervon Biopharmaceuticals LLC
Helixmith Co Ltd
Regulaxis SAS
SIFI SpA
Stem Cell Medicine Ltd
Twinpigbiolab Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas in the Insulin Like Growth Factor I pipeline drugs market?
The key therapy areas in the Insulin Like Growth Factor I pipeline drugs market are oncology, central nervous system, cardiovascular, metabolic disorders, musculoskeletal disorders, and ophthalmology.
-
What are the key mechanisms of action in the Insulin Like Growth Factor I pipeline drugs market?
The key mechanisms of action in the Insulin Like Growth Factor I pipeline drugs market are Insulin Like Growth Factor I Inhibitor, and Insulin Like Growth Factor I Activator.
-
What are the key routes of administration in the Insulin Like Growth Factor I pipeline drugs market?
The key routes of administration in the Insulin Like Growth Factor I pipeline drugs market are intravenous, intramuscular, intravenous bolus, and ophthalmic.
-
What are the key molecule types in the Insulin Like Growth Factor I pipeline drugs market?
The molecule types in the Insulin Like Growth Factor I pipeline drugs market are monoclonal antibody, synthetic peptide, cell therapy, gene therapy, peptide, and recombinant protein.
-
Which are the leading companies in the Insulin Like Growth Factor I pipeline drugs market?
Some of the leading companies in the Insulin Like Growth Factor I pipeline drugs market are Boehringer Ingelheim International GmbH, Genervon Biopharmaceuticals LLC, Helixmith Co Ltd, Regulaxis SAS, SIFI SpA, and Stem Cell Medicine Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.